Skip to main content
profile image
Selected Works of Gerald Sokol, MD, MSc, FCP
Article
Phase II trial of SM 88 in non-metastatic biochemical recurrent prostate cancer.
Journal of Clinical Oncology (2018)
  • Mack Roach, University of California, San Francisco
  • Zachary Gostout, Tyme Technologies, Inc., New York, NY;
  • Patricia Zawisny, Tyme Technologies, Inc., New York, NY;
  • Avi S. Retter, Eastchester Center for Cancer Care, Bergenfield, NJ;
  • Gerald H. Sokol, Florida Cancer Institute New Hope, Hudson, FL;
  • Steve Hoffman, Tyme Technologies, Inc., New York, NY;
  • Giuseppe Del Priore, Morehouse School of Medicine
Link
Disciplines
Publication Date
February 26, 2018
DOI
10.1200/JCO.2018.36.6_SUPPL.175
Citation Information
Mack Roach, Zachary Gostout, Patricia Zawisny, Avi S. Retter, et al.. "Phase II trial of SM 88 in non-metastatic biochemical recurrent prostate cancer." Journal of Clinical Oncology Vol. 36 (2018) p. 175 - 175
Available at: http://works.bepress.com/gerald-sokol/7/